Watch TWST. Know when insiders buy.
One email the day a filing lands. Free.
TWST
Twist Bioscience Corp
149.13
+6.43 +4.51%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
59
WATCH · insiders 25, shorts 92
Insiders, 90 days
−$98.3M
net selling · 0 buys, 66 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $9.4BP/E —DIV YIELD —FCF YIELD -1.00%REV TTM —NET INCOME −$136.7MNET CASH $113.3M52W 25.45 – 205.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Jun 30 | — | — | — | −$36.3M | −$35.1M | −271.9% | -0.56 | $1.1M | $9.8M | −$8.6M | Aug 3 |
| Q2 2026 · Mar 31 | — | — | — | −$45.9M | −$44M | — | -0.71 | −$17.6M | $7.9M | −$25.4M | May 4 |
| Q1 2026 · Dec 31 | — | — | — | −$32.9M | −$30.5M | — | -0.50 | −$24.8M | $10M | −$34.8M | Feb 26 |
| Q4 2025 · Sep 30derived | — | — | — | −$29.9M | −$27.1M | — | -0.45 | −$11.8M | $12.4M | −$24.2M | Nov 17 |
| Q3 2025 · Jun 30 | — | — | — | −$30.1M | $20.4M | — | 0.33 | −$1.4M | $9.2M | −$10.6M | Aug 3 |
| Q2 2025 · Mar 31 | — | — | — | −$41.6M | −$39.3M | — | -0.66 | −$13M | $4.1M | −$17.1M | May 4 |
| Q1 2025 · Dec 31 | — | — | — | −$34.6M | −$31.6M | — | -0.53 | −$21.4M | $2.3M | −$23.7M | Feb 26 |
| Q4 2024 · Sep 30derived | — | — | — | −$36M | −$34.7M | — | -0.59 | −$15.3M | $2M | −$17.3M | Nov 17 |
| Q3 2024 · Jun 30 | — | — | — | −$88.9M | −$85.6M | — | -1.47 | −$6.4M | $965K | −$7.3M | Aug 4 |
| Q2 2024 · Mar 31 | — | — | — | −$48.9M | −$45.5M | — | -0.79 | −$19.4M | $603K | −$20M | May 5 |
| Q1 2024 · Dec 31 | — | — | — | −$47M | −$43M | — | -0.75 | −$23M | $1.5M | −$24.5M | Feb 3 |
| Q4 2023 · Sep 30derived | — | — | — | −$50.1M | −$46.2M | — | -0.81 | −$20.7M | $2.4M | −$23.1M | Nov 17 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Sep 30 | — | — | −$136.3M | −$77.7M | — | -1.30 | −$47.6M | $28M | −$75.6M | — | — |
| FY2024 · to Sep 30 | — | — | −$220.8M | −$208.7M | — | -3.60 | −$64.1M | $5.1M | −$69.2M | — | — |
| FY2023 · to Sep 30 | — | — | −$217.2M | −$204.6M | — | -3.60 | −$142.5M | $27.8M | −$170.3M | — | — |
| FY2022 · to Sep 30 | — | — | −$234.8M | −$217.9M | — | -4.04 | −$124.4M | $101.9M | −$226.2M | — | — |
| FY2021 · to Sep 30 | — | — | −$152.7M | −$152.1M | — | -3.15 | −$112.2M | $27.1M | −$139.3M | — | — |
| FY2020 · to Sep 30 | — | — | −$140.1M | −$139.9M | — | -3.57 | −$142.3M | $9.9M | −$152.1M | — | — |
Every number comes from Twist Bioscience Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.